Development of EGF-conjugated liposomes for targeted delivery of boronated DNA-binding agents

Bioconjugate Chemistry

Volumn 13, Issue 4, 2002, Pages 737-743

  Bohl Kullberg, Erika ^a   Bergstrand, Nill ^b   Carlsson, Jörgen ^a   Edwards, Katarina ^b   Johnsson, Markus ^b   Sjöberg, Stefan ^b   Gedda, Lars ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CONTROLLED DRUG DELIVERY; DISEASE CONTROL; DISEASES; MOLECULES; TARGETED DRUG DELIVERY;

CANCER DISEASE; CONJUGATED LIPOSOMES; DNA-BINDING AGENT; DRUG DELIVERY TOOLS; EPIDERMAL GROWTH FACTORS; INFECTIOUS DISEASE; LIPID MOLECULES; PEG-DSPE; TARGETED DELIVERY; TRANSFER METHOD;

LIPOSOMES;

ACRIDINE DERIVATIVE; BORON DERIVATIVE; EPIDERMAL GROWTH FACTOR; INTERCALATING AGENT; LIPOSOME; MACROGOL DERIVATIVE; PHOSPHATIDYLETHANOLAMINE; POLYETHYLENE GLYCOL DISTEAROYLPHOSPHATIDYLETHANOLAMINE; POLYETHYLENE GLYCOL-DISTEAROYLPHOSPHATIDYLETHANOLAMINE; TUMOR PROTEIN;

ANIMAL; ARTICLE; CELL CULTURE; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG STABILITY; GLIOMA; HUMAN; METABOLISM; METHODOLOGY; MOUSE; NEUTRON CAPTURE THERAPY; PATHOLOGY; RADIOASSAY; SENSITIVITY AND SPECIFICITY;

ACRIDINES; ANIMALS; BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EPIDERMAL GROWTH FACTOR; GLIOMA; HUMANS; INTERCALATING AGENTS; LIPOSOMES; MICE; NEOPLASM PROTEINS; PHOSPHATIDYLETHANOLAMINES; POLYETHYLENE GLYCOLS; RADIOLIGAND ASSAY; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 0036077205     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc0100713     Document Type: Article

References (31)

1. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors
2. Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes
3. Selective boron delivery to murine tumors by lipophilic species incorporated in the membranes of unilamellar liposomes
4. Selective in vivo localization of daunorubicin small unilamellar vesicles in solid tumors
5. Liposomes with prolonged blood circulation and selective localization in Klebsiella pneumoniae-infected lung tissue
6. Sterically stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacy
7. Prolonged circulation time in vivo of large unilamelar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol)
8. Amphipathic poly(ethylene glycol)s effectively prolong the circulation time of liposomes
9. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo
10. A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells
11. Amplified genes in human gliomas
12. Synthesis of novel Boronated Acridines- and Spermidines as possible agents for BNCT
13. Optimization of drug loading procedures and characterization of liposomal formulations of two novel agents intended for boron neutron capture therapy (BNCT)
14. Biological effects and therapeutic possibilities of neutrons
15. Boron Neutron Capture Therapy of brain tumors: Past history, current status and future potential
16. A combinatorial approach to producing sterically stabilized (Stealth) immunoliposomal drugs
17. Insertion of poly(ethylene glycol) derivatized phospholipid into preformed liposomes results in prolonged in vivo circulation time
18. Properties of human malignant glioma cells in vitro
19. Sterically stabilized anti-HER2 immunoliposomes: Design and targeting to human breast cancer cells in vitro
20. Spherical micelles and other self-assembled structures in dilute aqueous mixtures of poly(ethylene glycol)-lipids
21. Effects of PEG-lipids on permeability of phosphatidylcholine/cholesterol liposomes in buffer and in human serum
22. Preparation of EGF labeled liposomes and their uptake by hepatocytes
23. Efficient gene transfer to EGF receptor overexpressing cancer cells by means of EGF-labeled cationic liposomes
24. Specific targeting with poly(ethylene glycol)-modified liposomes: Coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times
25. An analytic dosimetry study for the use of radionuclide-liposome conjugates in internal radiotherapy
26. Radiation dose heterogeneity in receptor and antigen mediated boron neutron capture therapy
27. Model studies directed toward the boron neutron-capture therapy of cancer: Boron delivery to murine tumors with liposomes
28. Liposomes as drug delivery vehicles for boron agents
29. Liposomal formulations containing sodium mercaptoundecahydrododecaborate (BSH) for boron neutron capture therapy
30. Preparation and characterization of liposomal systems entrapping the boronated compound o-carboranylpropylamine
31. Conjugate chemistry and cellular processing of EGF-Dextran